Dr Philip Choi

Contacts

BA (UNSW), BSc(Med) MBBS (UNSW), PhD (UNSW), FRCPA, FRACP
Honorary Senior Lecturer
  • Principal Editor: Platelets
  • The Canberra Hospital, August 2015-current
  • National Capital Private Hospital, August 2015-current
  • St George Clinical School (UNSW), PhD student, 2011-2016
  • St George Private Hospital, Kogarah, VMO 2011-current
  • St George Public Hospital, Kogarah 2010-2012
  • Concord Repatriation General Hospital (CRGH) 2005-2009
  • Royal Prince Alfred Hospital (RPAH) 2002-2009
  • University of NSW (UNSW) 1995-2001
  • Clinical Schools: St George Hospital 1997, POWH 1998, SVH 1999-2001

 

 

 

Choi PY, Roncolato F, Badoux X, Ramanathan S, Ho SJ, Chong BH. A novel triple therapy for ITP using high dose dexamethasone, low dose rituximab and cyclosporine (TT4). Blood. 2015;126(4):500-3.

Iraqi M, Perdomo J, Yan F, Choi PY, Chong BH. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro. Haematologica. 2015;100(5):623-32.

Chong BH, Choi PY, Khachigian L, Perdomo J. Drug-induced immune thrombocytopenia. Hematol Oncol Clin North Am. 2013;27(3):521- 40.

Choi PY, Gordon JE, Harvey M, Chong BH. Presentation and outcome of idiopathic thrombocytopenic purpura in a single Australian centre. Intern Med J. 2012;42(7):841-5.

Choi PY, Rasko JEJ. The challenge of investigating thrombocytopenia. Medicine Today. 2011;12(2):26-35.

Choi PY, Phillips KL, Rae I. High-dose intravenous flucloxacillin may affect warfarin therapy. Med J Aust. 2011;194(11):613.

Choi PY, Dunkley S, Rasko JEJ. Immune thrombocytopenia: a diganosis of exclusion. Medicine Today. 2011;12(3):41-6.

Choi PY, Gibson J. Assessment of Haemostasis - Part 3. Medical Observer. 2010;August(27):23-5.

Choi PY, Gibson J. Assessment of Haemostasis - Part 2. Medical Observer. 2010;August(20):27-9.

Choi PY, Gibson J. Assessment of Haemostasis - Part 1. Medical Observer. 2010;August(13):23-5.

Choi P. Perinephric Haematopoiesis. MJA 2008; 188 (4): 250